These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain. Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099 [TBL] [Abstract][Full Text] [Related]
3. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice. Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240 [TBL] [Abstract][Full Text] [Related]
4. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482 [TBL] [Abstract][Full Text] [Related]
5. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity. Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves. Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684 [TBL] [Abstract][Full Text] [Related]
7. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells. De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685 [TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium. Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627 [TBL] [Abstract][Full Text] [Related]
9. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization. Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298 [TBL] [Abstract][Full Text] [Related]
10. CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages. Samudra AN; Dwyer KM; Selan C; Freddi S; Murray-Segal L; Nikpour M; Hickey MJ; Peter K; Robson SC; Sashindranath M; Cowan PJ; Nandurkar HH J Autoimmun; 2018 Mar; 88():131-138. PubMed ID: 29103803 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Geraghty NJ; Watson D; Sluyter R Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314 [TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling: a potential therapeutic target for ischemic stroke. Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253 [TBL] [Abstract][Full Text] [Related]
14. The role of the CD39-CD73-adenosine pathway in liver disease. Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591 [TBL] [Abstract][Full Text] [Related]
15. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients. Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834 [TBL] [Abstract][Full Text] [Related]